Skip to main content

SUMMIT SECURITIES GROUP LLC

Broker-Dealer

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1531593 NEW YORK, NY

Position in TEVA

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$237,160
+$11,260 QoQ
Shares Held
7,000
-6.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#480
of 671 holders
Holding Since
Mar 2021
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Mar 31, 2021
CallValue
$2,492
CallShares
216
PutValue
$2,492
PutShares
216

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUMMIT SECURITIES GROUP LLC holds $650,751 across 9 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (36.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
This page
7,000 $237,160

All Filings in TEVA

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $237,160 7,000
2026-03-31 $225,900 7,500
2025-12-31 $187,260 6,000
2025-09-30 $80,173 3,969
2024-06-30 $365,625 22,500
2021-03-31 $2,492 216
2021-03-31 $2,492 216